Objectives: Cytomegalovirus infection (CMVi) occurs frequently in transplant patients. Co-inhibitory molecules on CMV-specific T-cells (TCMV) in patients after lung transplantation were investigated.
Methods: 59 lung transplant patients were stratified according to anti-CMV serostatus at time of transplantation.